Skip to main content

Loteprednol etabonate and tobramycin

NDC 82260-358 · Bausch & Lomb Americas Inc.

Generic nameloteprednol etabonate and tobramycin
Dosage formSOLUTION/ DROPS
RouteOPHTHALMIC
Active ingredient(s)LOTEPREDNOL ETABONATE, TOBRAMYCIN
Strength5; 3 mg/mL; mg/mL
Pharmacologic classAminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
Marketing categoryNDA AUTHORIZED GENERIC

Packages

82260-358-05 — 1 BOTTLE, DROPPER in 1 CARTON (82260-358-05) / 5 mL in 1 BOTTLE, DROPPER

82260-358-10 — 1 BOTTLE, DROPPER in 1 CARTON (82260-358-10) / 10 mL in 1 BOTTLE, DROPPER

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

72485-653 — Loteprednol Etabonate, 72485-665 — Loteprednol Etabonate, 72603-324 — LOTEPREDNOL ETABONATE, 72603-430 — Tobramycin, 72603-630 — Tobramycin, 76204-029 — Tobramycin, 76420-092 — Tobramycin, 76420-791 — Tobramycin, 80425-0260 — Tobramycin and dexamethasone, 80425-0341 — Tobramycin, 80425-0366 — Tobramycin and Dexamethasone, 82260-299 — loteprednol etabonate, 82260-361 — loteprednol etabonate, 82260-508 — loteprednol etabonate, 82667-011 — tobramycin / dexamethasone, 85766-025 — Tobramycin, 85766-188 — Tobramycin and Dexamethasone, 85766-189 — Tobramycin, 85766-193 — Loteprednol Etabonate, 86211-110 — Tobramycin, +85 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels